FindTrial
Sign In

To assess the effect of Bharamari Pranayama on anxiety and depression in type 2 diabetes mellitus patients

EFFICACY OF BHRAMARI PRANAYAMA IN THE MANAGEMENT OF ANXIETY AND DEPRESSION IN TYPE 2 DIABETES MELLITUS PATIENTS A RANDOMIZED CONTROLLED CLINICAL STUDY - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/05/111216
Enrollment
60
Registered
2026-05-27
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F01-F99- Mental, Behavioral and Neurodevelopmental disorders

Interventions

None listed

Sponsors

Dr Muskan Agrawal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Type 2 diabetes mellitus patients suffering with mild to moderate anxiety and depression individually or combined, diagnosed by GAD-7, PHQ-9 questionnaire will be included in the study. 2. Patients between the age group of 30 to 70 years irrespective of their religion, gender and socioeconomic status. 3. Patients either previously diagnosed with Type 2 Diabetes Mellitus or newly confirmed at screening with Fasting Blood Glucose up to 250 mg/dl as per standard guidelines. 4. Patients on stable anti-diabetic treatment or not taking any medication but diagnosed with Type 2 diabetes mellitus. 5. Patients ready to sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with other psychiatric illness such as schizophrenia, bipolar disorder. 2. Type 2 diabetes mellitus patients suffering with other serious co-morbidities. 3. Patients with chronic respiratory disease such as Chronic Obstructive Pulmonary Disease, Severe Asthma. 4. Patients suffering with serious complication of diabetes such as Nephropathy, Vasculopathy. 5. Pregnant and lactating women. 6. Patients on anti-anxiety or anti-depression medication or other psychotropic medication and/or psychotherapy will be excluded. 7. Patients with Type-I Diabetes Mellitus (IDDM).

Design outcomes

Primary

MeasureTime frame
The proposed study will be expected to provide Bhramari Pranayama significant reduction in level of Anxiety and Depression with Type 2 Diabetes Mellitus Patients and enhancing overall patient well-being.Timepoint: 45 days—

Secondary

MeasureTime frame
It is also expected that this study would be able to find out the positive influence of Bhramari Pranayama on Fasting Blood Sugar Level and Inflammatory Markers.Timepoint: 45 days—

Countries

India

Contacts

Public ContactDr Charu Bansal

Pt. Khushilal Sharma Government (autonomous) Ayurveda college and Institute Nehru Nagar Bhopal M.P.

bansalcharu@ymail.com9425017573

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026